BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024

Core Viewpoint - BioNTech SE will announce its financial results for Q3 2024 on November 4, 2024, and will host a conference call and webcast for stakeholders to discuss these results and provide corporate updates [1]. Company Overview - BioNTech is a global next-generation immunotherapy company focused on developing novel therapies for cancer and other serious diseases, utilizing a variety of computational discovery and therapeutic drug platforms [3]. - The company has a diverse oncology product portfolio, including individualized and off-the-shelf mRNA-based therapies, CAR T cells, protein-based therapeutics, and small molecules [3]. - BioNTech is also developing multiple mRNA vaccine candidates for infectious diseases, leveraging its expertise in mRNA vaccine development and in-house manufacturing capabilities [3]. - The company has established collaborations with various global pharmaceutical partners, including Pfizer, Genentech, and Regeneron, among others [3].